- Pauline M. Rudd - PI
- Barbara Keegan - PA/Administrator (to Professor Pauline M. Rudd)
Niaobh O'Donoghue, PhD - Lab Manager
Principal Investigator
Post-Docs
- Giorgio Carta - Bioinformatics
- Eoin Cosgrave - Fc Receptor Glycobiology
- Margaret Doherty - Technology Development
- Eugene Dempsey - Cell signalling in Cancer
- Rebecca Duke - Glycobiology of O-linked glycans
- Mark Hilliard - Mass Spectrometry Development and Analytics
- Jayesh Kattla - Training and Research
- Karina Marino- Alimentary Glycoscience Research Cluster
- Niaobh O'Donoghue - Lab Manager
- John O'Rourke - Bioinformatics
- Oscar Potter - Technology Development
- Radka Saldova-Fahey - Glycobiology and Cancer
- Michael Schomberg - Technology Development
- Weston Struwe - Mass Spectrometry Development and Analytics
- Jayne Telford - Glycobiology and Disease
- Tharmala Tharmalingam - Reproductive Biology Research Cluster
Research Assistants
- Barbara Adamczyk - Glycobiology and Disease
- Patrick Jennings - Glycobiology and Disease
- Joanne Withers - Glycobiology and Disease
PhD Student
- Marie Galligan- Statistics
Former members
- Jonathan Bones
- Matthew Campbell
- Li Liu
- Jodie Abrahams
- Jennifer Byrne
- Marion Boland
- Ronan Kelly
- Ciara McManus
- Natalia Artemenko
Current Area of Interest
I have been employed with NIBRT since October 2007. My role in NIBRT is to manage the Dublin-Oxford Glycobiology Laboratory, headed by Prof. Pauline M. Rudd and to manage NIBRT’s custom Analytical Glycobiology Services for the worldwide scientific and biopharmaceutical industries.
My research background is in Clinical Pharmacology where I specialised in proteomics and mass spectrometry as tools for research in this field. My PhD thesis was entitled the Proteomic Analysis of the Platelet Pharmacological Response. I have had the opportunity over the past number of years to work with diverse research groups utilising mass spectrometry as a tool to assist them with answering their biological questions.
My current research interests are based on analytical method development for the elucidation of glycan structures in both clinical samples and glycotherapeutics.
Other Information
Contact Information
Email:follow this link